SCHEMBL13316656

SCHEMBL13316656

COCOC(C=O)c1ccc(Cc2cccc(Cl)c2F)cn1

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 1/20 0.34
SLC22A12 Q96S37 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13316654 0.82 KLKB1 (0.33) KLKB1SLC22A12
SCHEMBL13316652 0.77
SCHEMBL13349621 0.75
SCHEMBL13349710 0.73 CXCR2 (0.32) KLKB1SLC22A12
SCHEMBL13316641 0.73 CCNT1 (0.34) KLKB1SLC22A12
SCHEMBL13316618 0.71
SCHEMBL13316614 0.70 CYP3A4 (0.42)
SCHEMBL13349598 0.69 CXCR2 (0.32) KLKB1SLC22A12
SCHEMBL13349624 0.69
SCHEMBL13349597 0.68 CXCR2 (0.34) KLKB1SLC22A12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745459-B2 Quinolizinone compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2010-06-29 US disclosed
US-7745459-B2 Quinolizinone compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2010-06-29 US disclosed